BA
MDXG icon

Boston Advisors’s MiMedx Group MDXG Stock Holding History

Boston Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-57,203
Closed -$721K – 655
2017
Q4 		$721K Buy
57,203
+2,020
+4% +$24.6K 0.02% 432
2017
Q3 		$656K Buy
55,183
+280
+0.5% +$4.15K 0.01% 437
2017
Q2 		$822K Sell
54,903
-19,891
-27% -$265K 0.02% 401
2017
Q1 		$713K Sell
74,794
-5,415
-7% -$45.7K 0.02% 404
2016
Q4 		$711K Buy
80,209
+13,981
+21% +$126K 0.02% 407
2016
Q3 		$568K Buy
66,228
+4,690
+8% +$37.1K 0.01% 476
2016
Q2 		$491K Buy
61,538
+9,155
+17% +$71.2K 0.01% 483
2016
Q1 		$458K Sell
52,383
-780
-1% -$6.48K 0.01% 479
2015
Q4 		$498K Buy
53,163
+3,470
+7% +$30.1K 0.01% 459
2015
Q3 		$480K Sell
49,693
-2,840
-5% -$30K 0.02% 533
2015
Q2 		$609K Sell
52,533
-415
-0.8% -$4.27K 0.03% 422
2015
Q1 		$551K Buy
52,948
+24,250
+85% +$227K 0.02% 447
2014
Q4 		$331K Buy
+28,698
New +$283K 0.01% 444

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boston Advisors's MDXG Position: Q1 2018 in Review

Boston Advisors sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 57,203 shares — an estimated $721K sold.

Boston Advisors first reported a position in MDXG in Q4 2014 and held it in 13 quarters. The position peaked at $822K in Q2 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

  • Boston Advisors reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
  • Boston Advisors sold 57,203 MiMedx Group shares in Q1 2018, an estimated $721K.
  • Boston Advisors first reported a position in MiMedx Group in Q4 2014 and held it in 13 quarters.
  • Boston Advisors's MiMedx Group position peaked at $822K in Q2 2017.
  • 223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on Boston Advisors's 13F filing for Q1 2018, filed 25 Apr 2018.